Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 02/11 03:59:59 pm
135.36 USD   -2.49%
02/04 ALEXION PHARMAC : to Present at the Leerink Partners 5th Annual Glob..
02/03DJAlexion Pharmaceuticals Revenue Jumps, Profit Falls
02/03DJAlexion Pharmaceuticals Revenue Jumps But Profit Falls
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/05/2016 02/08/2016 02/09/2016 02/10/2016 02/11/2016 Date
142.28(c) 139.15(c) 136.46(c) 138.82(c) 135.38(c) Last
2 132 320 2 146 264 2 559 822 1 758 532 1 389 905 Volume
-2.56% -2.20% -1.93% +1.73% -2.48% Change
More quotes
Financials ($)
Sales 2016 3 103 M
EBIT 2016 1 378 M
Net income 2016 722 M
Debt 2016 1 565 M
Yield 2016 -
Sales 2017 3 820 M
EBIT 2017 1 819 M
Net income 2017 1 224 M
Finance 2017 265 M
Yield 2017 -
P/E ratio 2016 44,54
P/E ratio 2017 26,82
EV / Sales 2016 10,6x
EV / Sales 2017 8,12x
Capitalization 31 275 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
02/11 | 01:50pmPresentation
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
02/04 ALEXION PHARMACEUTICALS : to Present at the Leerink Partners 5th Annual Global H..
02/03 ALEXION PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
02/03DJAlexion Pharmaceuticals Revenue Jumps, Profit Falls
02/03DJAlexion Pharmaceuticals Revenue Jumps But Profit Falls
02/03 ALEXION PHARMACEUTICALS : tops 4Q profit forecasts
02/03 ALEXION PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2015 Results and ..
01/20 ALEXION PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2015 Results on..
01/15 ALEXION PHARMACEUTICALS : Researchers to Present New Data at ENDO 2016 Advancing..
More news
Sector news : Biopharmaceuticals
05:01p TEVA PHARMACEUTICAL : Files 2015 Annual Report on Form 20-F
03:37p TEVA PHARMACEUTICAL : Falling Copaxone sales hit Teva Q4 results
02:38p ROCHE BEARER SHARE : Broadens Test System to Include Additional Virology Assays
More sector news : Biopharmaceuticals
News from SeekingAlpha
10:01a The Touchstone Sands Capital Institutional Growth Fund Is Feeling The Pain
02/09 INSIDERINSIGHTS.COM DAILY ROUND UP 2 : Cfr, enh, an, hear
02/08 Why The Stock Market Decline Faces Additional Selling Pressure
02/04 Celgene Is Down Enough To Be Bought - Cramer's Lightning Round (2/3/16)
02/03 Alexion Pharmaceuticals' (ALXN) CEO David Hallal on Q4 2015 Results - Earning..


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions